SLNTY yields 11.90% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, SLNTY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SLNTY + PFE for your $10,000?
Solutions 30 SE provides support solutions for new digital technologies in France, Italy, Germany, the Netherlands, Belgium, Luxembourg, Poland, and Spain. The company offers telecom support services, including installation, assistance using communications equipment, deployment of telecommunication infrastructure, maintenance, and logistics. It also provides IT solutions, such as installation and maintenance of IT hardware, IT infrastructure, and servers; implementation of automatized robotic processes; deployment and maintenance of Internet of Things; TOTEM/KIOSK design, manufacturing, installation, and maintenance; console creation for data analytics; and logistics of spare parts and systems. In addition, the company installs and maintains smart meters; charging stations for electric vehicles; photovoltaic power plants for professional and residential markets; smart appliances comprising thermostats, light bulbs, plugs, and sensors; and L/H gas converters, as well as point of sale equipment and digital signs. Further, it deploys and maintains self-check-out technology and store digital infrastructure; installs wired and wireless connectivity, access control systems, and intrusion alarm systems; deploys fire alarm systems and video/CCTV; and offers cabling and logistics services. The company was incorporated in 2003 and is based in Luxembourg, Luxembourg.
Full SLNTY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.